{"id":1374,"date":"2024-09-25T11:08:03","date_gmt":"2024-09-25T11:08:03","guid":{"rendered":"https:\/\/fhucare.com\/event\/transdisciplinary-immunology-journal-club-1-jak-inhibition-enhances-checkpoint-blockade-immunotherapy-in-patients-with-hodgkin-lymphoma\/"},"modified":"2025-12-25T19:00:48","modified_gmt":"2025-12-25T18:00:48","slug":"transdisciplinary-immunology-journal-club-1-jak-inhibition-enhances-checkpoint-blockade-immunotherapy-in-patients-with-hodgkin-lymphoma","status":"publish","type":"post","link":"https:\/\/fhucare.com\/fr\/event\/transdisciplinary-immunology-journal-club-1-jak-inhibition-enhances-checkpoint-blockade-immunotherapy-in-patients-with-hodgkin-lymphoma\/","title":{"rendered":"Transdisciplinary Immunology Journal Club #1 JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma"},"content":{"rendered":"<p><span style=\"font-size: 18pt;color: #000000;background-color: #ffffff;font-family: helvetica\"><strong>Transdisciplinary Immunology Journal Club #TIJC<\/strong><\/span><\/p>\n<p><span style=\"font-family: helvetica\"><strong><span style=\"font-size: 14pt;background-color: #000000;color: #ffff00\">JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma<\/span><br \/><\/strong>Pr\u00e9sent\u00e9 par : <strong>Dr. Samuel Bitoun<br \/><\/strong>D\u00e9partement de rhumatologie H\u00f4pital Bic\u00eatre AP-HP, Universit\u00e9 Paris-Saclay, Inserm UMR1184, FHU CARE<\/span><br \/><span style=\"font-family: helvetica\">Date : <strong>Jeudi 7 novembre 2024<br \/><\/strong>Heure : <strong>17h00 \u2013 18h00<br \/><a href=\"https:\/\/youtu.be\/1k7rr2e4HxQ?si=rfk5Vm8aY4OLnY9f&amp;t=1\">Replay TIJC#1 : JAK Inhibitors and Cancer: Friend or Foe? par le Dr Samuel Bitoun, disponible ICI<\/a><br \/><\/strong><br \/><\/span><\/p>\n<p><span style=\"font-family: helvetica\">Venez explorer les nouvelles fronti\u00e8res de l&rsquo;immunologie \u00e0 travers la transdisciplinarit\u00e9 !<\/span><br \/><span style=\"font-family: helvetica\"><strong>Plus d\u2019info&nbsp;: <a href=\"en\/news-and-events\/bibliocare-l-alliance-des-connaissances-pour-reinventer-l-immunologie\">ici<\/a> <\/strong><\/span><\/p>\n<p><span style=\"color: #000000;font-family: helvetica\"><strong>Scientific Committee (non-exhaustive list):<\/strong><\/span><br \/><span style=\"color: #000000;font-family: helvetica\">Samuel Bitoun, Xavier Mariette,&nbsp; Fran\u00e7ois-Xavier Danlos, Camille Bigenwald, Beno\u00eet Kloeckner, Marie Naigeon, Matthieu Roulleaux Dugage, Ronan Flippot, Judith Michels, Marine Fidelle, Rami Bechara, etc.<\/span><\/p>\n<p><span style=\"font-family: helvetica\"><span style=\"font-size: 14pt\"><span style=\"color: #000000\"><strong>Explore new immunology frontiers through transdisciplinarity!&nbsp;<\/strong><\/span><\/span><span style=\"font-size: 14pt\"><span style=\"color: #000000\"><strong>Come explore the new frontiers of immunology together through transdisciplinarity!<\/strong><\/span><\/span><\/span><\/p>\n<p><span style=\"font-family: helvetica\"><strong>Lancement de la premi\u00e8re biblio du Transdisciplinary Immunology Journal Club&nbsp;! <\/strong>Nous avons le plaisir de vous inviter au lancement officiel du <strong>Transdisciplinary Immunology Journal Club<\/strong> (#TIJC), une initiative unique destin\u00e9e aux m\u00e9decins, chercheurs et \u00e9tudiants. Ce club a pour objectif de cr\u00e9er un espace d\u2019\u00e9changes transdisciplinaires autour des derni\u00e8res avanc\u00e9es en immunopathologie, avec une approche partag\u00e9e entre diverses sp\u00e9cialit\u00e9s m\u00e9dicales. C&rsquo;est une occasion rare de confronter diff\u00e9rentes perspectives pour am\u00e9liorer la prise en charge des patients.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Transdisciplinary Immunology Journal Club #TIJC JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphomaPr\u00e9sent\u00e9 par : Dr. Samuel BitounD\u00e9partement de rhumatologie H\u00f4pital Bic\u00eatre AP-HP, Universit\u00e9 Paris-Saclay, Inserm UMR1184, FHU CAREDate : Jeudi 7 novembre 2024Heure : 17h00 \u2013 18h00Replay TIJC#1 : JAK Inhibitors and Cancer: Friend or Foe? par le Dr Samuel Bitoun, [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1375,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"event_date":"Thursday, November 7, 2024","event_location":"Webinaire","event_time":"5 PM - 6 PM","footnotes":""},"categories":[10],"tags":[],"class_list":["post-1374","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-event"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Transdisciplinary Immunology Journal Club #1 JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma - FHU CARE\u00b2<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fhucare.com\/fr\/event\/transdisciplinary-immunology-journal-club-1-jak-inhibition-enhances-checkpoint-blockade-immunotherapy-in-patients-with-hodgkin-lymphoma\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Transdisciplinary Immunology Journal Club #1 JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma - FHU CARE\u00b2\" \/>\n<meta property=\"og:description\" content=\"Transdisciplinary Immunology Journal Club #TIJC JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphomaPr\u00e9sent\u00e9 par : Dr. Samuel BitounD\u00e9partement de rhumatologie H\u00f4pital Bic\u00eatre AP-HP, Universit\u00e9 Paris-Saclay, Inserm UMR1184, FHU CAREDate : Jeudi 7 novembre 2024Heure : 17h00 \u2013 18h00Replay TIJC#1 : JAK Inhibitors and Cancer: Friend or Foe? par le Dr Samuel Bitoun, [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fhucare.com\/fr\/event\/transdisciplinary-immunology-journal-club-1-jak-inhibition-enhances-checkpoint-blockade-immunotherapy-in-patients-with-hodgkin-lymphoma\/\" \/>\n<meta property=\"og:site_name\" content=\"FHU CARE\u00b2\" \/>\n<meta property=\"article:published_time\" content=\"2024-09-25T11:08:03+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-25T18:00:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/fhucare.com\/wp-content\/uploads\/2024\/09\/TIJC_1_flyer.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"1920\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"adm-fhuc2-la\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"adm-fhuc2-la\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/fhucare.com\\\/fr\\\/event\\\/transdisciplinary-immunology-journal-club-1-jak-inhibition-enhances-checkpoint-blockade-immunotherapy-in-patients-with-hodgkin-lymphoma\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fhucare.com\\\/fr\\\/event\\\/transdisciplinary-immunology-journal-club-1-jak-inhibition-enhances-checkpoint-blockade-immunotherapy-in-patients-with-hodgkin-lymphoma\\\/\"},\"author\":{\"name\":\"adm-fhuc2-la\",\"@id\":\"https:\\\/\\\/fhucare.com\\\/fr\\\/#\\\/schema\\\/person\\\/2e9ff2878c5ffade65bdda120c97b8e0\"},\"headline\":\"Transdisciplinary Immunology Journal Club #1 JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma\",\"datePublished\":\"2024-09-25T11:08:03+00:00\",\"dateModified\":\"2025-12-25T18:00:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/fhucare.com\\\/fr\\\/event\\\/transdisciplinary-immunology-journal-club-1-jak-inhibition-enhances-checkpoint-blockade-immunotherapy-in-patients-with-hodgkin-lymphoma\\\/\"},\"wordCount\":230,\"publisher\":{\"@id\":\"https:\\\/\\\/fhucare.com\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/fhucare.com\\\/fr\\\/event\\\/transdisciplinary-immunology-journal-club-1-jak-inhibition-enhances-checkpoint-blockade-immunotherapy-in-patients-with-hodgkin-lymphoma\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/fhucare.com\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/TIJC_1_flyer.jpeg\",\"articleSection\":[\"Event\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/fhucare.com\\\/fr\\\/event\\\/transdisciplinary-immunology-journal-club-1-jak-inhibition-enhances-checkpoint-blockade-immunotherapy-in-patients-with-hodgkin-lymphoma\\\/\",\"url\":\"https:\\\/\\\/fhucare.com\\\/fr\\\/event\\\/transdisciplinary-immunology-journal-club-1-jak-inhibition-enhances-checkpoint-blockade-immunotherapy-in-patients-with-hodgkin-lymphoma\\\/\",\"name\":\"Transdisciplinary Immunology Journal Club #1 JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma - FHU CARE\u00b2\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fhucare.com\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/fhucare.com\\\/fr\\\/event\\\/transdisciplinary-immunology-journal-club-1-jak-inhibition-enhances-checkpoint-blockade-immunotherapy-in-patients-with-hodgkin-lymphoma\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/fhucare.com\\\/fr\\\/event\\\/transdisciplinary-immunology-journal-club-1-jak-inhibition-enhances-checkpoint-blockade-immunotherapy-in-patients-with-hodgkin-lymphoma\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/fhucare.com\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/TIJC_1_flyer.jpeg\",\"datePublished\":\"2024-09-25T11:08:03+00:00\",\"dateModified\":\"2025-12-25T18:00:48+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/fhucare.com\\\/fr\\\/event\\\/transdisciplinary-immunology-journal-club-1-jak-inhibition-enhances-checkpoint-blockade-immunotherapy-in-patients-with-hodgkin-lymphoma\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/fhucare.com\\\/fr\\\/event\\\/transdisciplinary-immunology-journal-club-1-jak-inhibition-enhances-checkpoint-blockade-immunotherapy-in-patients-with-hodgkin-lymphoma\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/fhucare.com\\\/fr\\\/event\\\/transdisciplinary-immunology-journal-club-1-jak-inhibition-enhances-checkpoint-blockade-immunotherapy-in-patients-with-hodgkin-lymphoma\\\/#primaryimage\",\"url\":\"https:\\\/\\\/fhucare.com\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/TIJC_1_flyer.jpeg\",\"contentUrl\":\"https:\\\/\\\/fhucare.com\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/TIJC_1_flyer.jpeg\",\"width\":1080,\"height\":1920},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/fhucare.com\\\/fr\\\/event\\\/transdisciplinary-immunology-journal-club-1-jak-inhibition-enhances-checkpoint-blockade-immunotherapy-in-patients-with-hodgkin-lymphoma\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/fhucare.com\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Transdisciplinary Immunology Journal Club #1 JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/fhucare.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/fhucare.com\\\/fr\\\/\",\"name\":\"FHU CARE\u00b2\",\"description\":\"Innovations in Autoimmunity, Cancer &amp; Immunotherapies\",\"publisher\":{\"@id\":\"https:\\\/\\\/fhucare.com\\\/fr\\\/#organization\"},\"alternateName\":\"CARE2\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/fhucare.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/fhucare.com\\\/fr\\\/#organization\",\"name\":\"FHU CARE\u00b2\",\"alternateName\":\"CARE2\",\"url\":\"https:\\\/\\\/fhucare.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/fhucare.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/fhucare.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/CARE2-COULEUR.svg\",\"contentUrl\":\"https:\\\/\\\/fhucare.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/CARE2-COULEUR.svg\",\"caption\":\"FHU CARE\u00b2\"},\"image\":{\"@id\":\"https:\\\/\\\/fhucare.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/in\\\/fhucare\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@fhucare\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/fhucare.com\\\/fr\\\/#\\\/schema\\\/person\\\/2e9ff2878c5ffade65bdda120c97b8e0\",\"name\":\"adm-fhuc2-la\",\"sameAs\":[\"https:\\\/\\\/fhucare.com\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Transdisciplinary Immunology Journal Club #1 JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma - FHU CARE\u00b2","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fhucare.com\/fr\/event\/transdisciplinary-immunology-journal-club-1-jak-inhibition-enhances-checkpoint-blockade-immunotherapy-in-patients-with-hodgkin-lymphoma\/","og_locale":"fr_FR","og_type":"article","og_title":"Transdisciplinary Immunology Journal Club #1 JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma - FHU CARE\u00b2","og_description":"Transdisciplinary Immunology Journal Club #TIJC JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphomaPr\u00e9sent\u00e9 par : Dr. Samuel BitounD\u00e9partement de rhumatologie H\u00f4pital Bic\u00eatre AP-HP, Universit\u00e9 Paris-Saclay, Inserm UMR1184, FHU CAREDate : Jeudi 7 novembre 2024Heure : 17h00 \u2013 18h00Replay TIJC#1 : JAK Inhibitors and Cancer: Friend or Foe? par le Dr Samuel Bitoun, [&hellip;]","og_url":"https:\/\/fhucare.com\/fr\/event\/transdisciplinary-immunology-journal-club-1-jak-inhibition-enhances-checkpoint-blockade-immunotherapy-in-patients-with-hodgkin-lymphoma\/","og_site_name":"FHU CARE\u00b2","article_published_time":"2024-09-25T11:08:03+00:00","article_modified_time":"2025-12-25T18:00:48+00:00","og_image":[{"width":1080,"height":1920,"url":"https:\/\/fhucare.com\/wp-content\/uploads\/2024\/09\/TIJC_1_flyer.jpeg","type":"image\/jpeg"}],"author":"adm-fhuc2-la","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"adm-fhuc2-la","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/fhucare.com\/fr\/event\/transdisciplinary-immunology-journal-club-1-jak-inhibition-enhances-checkpoint-blockade-immunotherapy-in-patients-with-hodgkin-lymphoma\/#article","isPartOf":{"@id":"https:\/\/fhucare.com\/fr\/event\/transdisciplinary-immunology-journal-club-1-jak-inhibition-enhances-checkpoint-blockade-immunotherapy-in-patients-with-hodgkin-lymphoma\/"},"author":{"name":"adm-fhuc2-la","@id":"https:\/\/fhucare.com\/fr\/#\/schema\/person\/2e9ff2878c5ffade65bdda120c97b8e0"},"headline":"Transdisciplinary Immunology Journal Club #1 JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma","datePublished":"2024-09-25T11:08:03+00:00","dateModified":"2025-12-25T18:00:48+00:00","mainEntityOfPage":{"@id":"https:\/\/fhucare.com\/fr\/event\/transdisciplinary-immunology-journal-club-1-jak-inhibition-enhances-checkpoint-blockade-immunotherapy-in-patients-with-hodgkin-lymphoma\/"},"wordCount":230,"publisher":{"@id":"https:\/\/fhucare.com\/fr\/#organization"},"image":{"@id":"https:\/\/fhucare.com\/fr\/event\/transdisciplinary-immunology-journal-club-1-jak-inhibition-enhances-checkpoint-blockade-immunotherapy-in-patients-with-hodgkin-lymphoma\/#primaryimage"},"thumbnailUrl":"https:\/\/fhucare.com\/wp-content\/uploads\/2024\/09\/TIJC_1_flyer.jpeg","articleSection":["Event"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/fhucare.com\/fr\/event\/transdisciplinary-immunology-journal-club-1-jak-inhibition-enhances-checkpoint-blockade-immunotherapy-in-patients-with-hodgkin-lymphoma\/","url":"https:\/\/fhucare.com\/fr\/event\/transdisciplinary-immunology-journal-club-1-jak-inhibition-enhances-checkpoint-blockade-immunotherapy-in-patients-with-hodgkin-lymphoma\/","name":"Transdisciplinary Immunology Journal Club #1 JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma - FHU CARE\u00b2","isPartOf":{"@id":"https:\/\/fhucare.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/fhucare.com\/fr\/event\/transdisciplinary-immunology-journal-club-1-jak-inhibition-enhances-checkpoint-blockade-immunotherapy-in-patients-with-hodgkin-lymphoma\/#primaryimage"},"image":{"@id":"https:\/\/fhucare.com\/fr\/event\/transdisciplinary-immunology-journal-club-1-jak-inhibition-enhances-checkpoint-blockade-immunotherapy-in-patients-with-hodgkin-lymphoma\/#primaryimage"},"thumbnailUrl":"https:\/\/fhucare.com\/wp-content\/uploads\/2024\/09\/TIJC_1_flyer.jpeg","datePublished":"2024-09-25T11:08:03+00:00","dateModified":"2025-12-25T18:00:48+00:00","breadcrumb":{"@id":"https:\/\/fhucare.com\/fr\/event\/transdisciplinary-immunology-journal-club-1-jak-inhibition-enhances-checkpoint-blockade-immunotherapy-in-patients-with-hodgkin-lymphoma\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fhucare.com\/fr\/event\/transdisciplinary-immunology-journal-club-1-jak-inhibition-enhances-checkpoint-blockade-immunotherapy-in-patients-with-hodgkin-lymphoma\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/fhucare.com\/fr\/event\/transdisciplinary-immunology-journal-club-1-jak-inhibition-enhances-checkpoint-blockade-immunotherapy-in-patients-with-hodgkin-lymphoma\/#primaryimage","url":"https:\/\/fhucare.com\/wp-content\/uploads\/2024\/09\/TIJC_1_flyer.jpeg","contentUrl":"https:\/\/fhucare.com\/wp-content\/uploads\/2024\/09\/TIJC_1_flyer.jpeg","width":1080,"height":1920},{"@type":"BreadcrumbList","@id":"https:\/\/fhucare.com\/fr\/event\/transdisciplinary-immunology-journal-club-1-jak-inhibition-enhances-checkpoint-blockade-immunotherapy-in-patients-with-hodgkin-lymphoma\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/fhucare.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Transdisciplinary Immunology Journal Club #1 JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma"}]},{"@type":"WebSite","@id":"https:\/\/fhucare.com\/fr\/#website","url":"https:\/\/fhucare.com\/fr\/","name":"FHU CARE\u00b2","description":"Innovations in Autoimmunity, Cancer &amp; Immunotherapies","publisher":{"@id":"https:\/\/fhucare.com\/fr\/#organization"},"alternateName":"CARE2","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fhucare.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/fhucare.com\/fr\/#organization","name":"FHU CARE\u00b2","alternateName":"CARE2","url":"https:\/\/fhucare.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/fhucare.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/fhucare.com\/wp-content\/uploads\/2025\/11\/CARE2-COULEUR.svg","contentUrl":"https:\/\/fhucare.com\/wp-content\/uploads\/2025\/11\/CARE2-COULEUR.svg","caption":"FHU CARE\u00b2"},"image":{"@id":"https:\/\/fhucare.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/in\/fhucare\/","https:\/\/www.youtube.com\/@fhucare\/"]},{"@type":"Person","@id":"https:\/\/fhucare.com\/fr\/#\/schema\/person\/2e9ff2878c5ffade65bdda120c97b8e0","name":"adm-fhuc2-la","sameAs":["https:\/\/fhucare.com"]}]}},"_links":{"self":[{"href":"https:\/\/fhucare.com\/fr\/wp-json\/wp\/v2\/posts\/1374","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fhucare.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fhucare.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fhucare.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/fhucare.com\/fr\/wp-json\/wp\/v2\/comments?post=1374"}],"version-history":[{"count":2,"href":"https:\/\/fhucare.com\/fr\/wp-json\/wp\/v2\/posts\/1374\/revisions"}],"predecessor-version":[{"id":2392,"href":"https:\/\/fhucare.com\/fr\/wp-json\/wp\/v2\/posts\/1374\/revisions\/2392"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fhucare.com\/fr\/wp-json\/wp\/v2\/media\/1375"}],"wp:attachment":[{"href":"https:\/\/fhucare.com\/fr\/wp-json\/wp\/v2\/media?parent=1374"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fhucare.com\/fr\/wp-json\/wp\/v2\/categories?post=1374"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fhucare.com\/fr\/wp-json\/wp\/v2\/tags?post=1374"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}